Related Experiment Video
Updated: Aug 29, 2026
Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria
Fabiola Espejo1, Adriana Bermúdez, Elizabeth Torres
1Fundación Instituto de Inmunología de Colombia (FIDIC), Universidad Nacional de Colombia-Bogotá, Cra. 50 No. 26-00, Bogotá, Colombia.
Abstract:
Immunogenic and protective peptide sequences are of prime importance in the search for an anti-malarial vaccine. The MSP-1 conserved and semi-conserved sequences have been shown to contain red blood cell (RBC) membrane high affinity binding peptides (HABP). HABP 1513 sequence ((42)GYSLFQKEKMVLNEGTSGTA(61)), from this protein's N-terminal, has been shown to possess a T-epitope; however, it did not induce a humoral immune response or complete protection when evaluated in Aotus monkeys. Analogue peptides with critical binding residues replaced by amino acids with similar mass but different charge were synthesised and tested for immunogenicity and protectivity in monkey. NMR studies correlated structural behaviour with biological function. Non-immunogenic and non-protective 1513 native peptide presented a helical fragment between residues L(4) and E(14). C-terminal, 5-residue-shorter, non-immunogenic, non-protective peptide 17894 contained an alpha-helix from Q(6) to L(12) residues. Immunogenic and protective peptide 13946 presented a shorter alpha-helix between K(7) to N(13) residues. These data suggest that changing certain residues permits better peptide fit within the MHC class II-peptide-TCR complex, thus activating the immune system and inducing a protective immune response.
Insights
Developing an anti-malarial vaccine requires immunogenic peptides. Modifying specific amino acids in malaria parasite protein sequences enhances T-cell activation and immune protection in Aotus monkeys.
Area of Science:
- Immunology
- Vaccinology
- Structural Biology
Background:
- Developing an effective anti-malarial vaccine is crucial.
- Malaria parasite protein 1 (MSP-1) contains high-affinity binding peptides (HABPs) with potential T-epitopes.
- The native HABP 1513 peptide showed T-epitope activity but failed to induce immunity or protection in Aotus monkeys.
Purpose of the Study:
- To investigate the immunogenicity and protective capacity of modified HABP analogues.
- To correlate structural changes in peptides with their biological function and immune response.
Main Methods:
- Synthesis of analogue peptides with altered residues (similar mass, different charge).
- Evaluation of peptide immunogenicity and protective efficacy in Aotus monkeys.
- Nuclear Magnetic Resonance (NMR) studies to determine peptide structural conformation.
Main Results:
- Native peptide 1513 and shorter analogue 17894 were non-immunogenic and non-protective, exhibiting helical structures.
- Modified peptide 13946 demonstrated immunogenicity and protective effects.
- NMR revealed distinct helical fragment lengths correlating with immunogenicity and protection.
Conclusions:
- Modifying specific residues in MSP-1 derived peptides can enhance their immunogenicity and protective potential.
- Structural conformation, particularly alpha-helix stability, influences peptide interaction with the MHC class II-peptide-TCR complex.
- Optimized peptide structures are key to activating the immune system for a protective anti-malarial response.
More Related Videos
09:25CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
08:46Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
Related Concept Videos
01:29Malaria
01:21Antiprotozoal Agents